Invention Grant
- Patent Title: Sustained release delivery of active agents to treat glaucoma and ocular hypertension
-
Application No.: US14136024Application Date: 2013-12-20
-
Publication No.: US09610271B2Publication Date: 2017-04-04
- Inventor: Suzanne Cadden , Yong Hao , Deepank Utkhede , Valery Rubinchik , Charles Richard Kjellbotn
- Applicant: Mati Therapeutics, Inc.
- Applicant Address: US TX Austin
- Assignee: Mati Therapeutics Inc.
- Current Assignee: Mati Therapeutics Inc.
- Current Assignee Address: US TX Austin
- Agency: Mati Therapeutics Inc.
- Agent Koren Anderson
- Main IPC: A61K31/216
- IPC: A61K31/216 ; A61L31/16 ; A61P27/06 ; A61K9/00 ; A61F9/00 ; A61F9/007

Abstract:
A method of decreasing intraocular pressure (IOP) in an eye of a patient in need thereof includes implanting a first lacrimal implant through a firsts punctum and into a first lacrimal canaliculus of the eye of the patient. The method may further comprise implanting a second lacrimal implant through a second punctum and into a second lacrimal canaliculus of the eye of the patient, and releasing, on a sustained basis a therapeutically effective amount of an intraocular pressure-reducing therapeutic agent.
Public/Granted literature
- US20140350103A1 SUSTAINED RELEASE DELIVERY OF ACTIVE AGENTS TO TREAT GLAUCOMA AND OCULAR HYPERTENSION Public/Granted day:2014-11-27
Information query